The full management from first-line to third-line treatments in patients with Her-2–negative advanced gastric cancer

BACKGROUND: The aim of this study was to retrospectively evaluate the efficacy of full management from first-line to third-line treatments in patients with human epidermal growth factor receptor 2 (Her-2)–negative advanced gastric cancer (GC). METHODS: The efficacy and survival time of a total of 12...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chunxiao, Pei, Yanqing, Xu, Jun, Zhang, Wenyu, Zhang, Jianbo, Shi, Shengbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705955/
https://www.ncbi.nlm.nih.gov/pubmed/36457494
http://dx.doi.org/10.3389/fonc.2022.949941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705955/
https://www.ncbi.nlm.nih.gov/pubmed/36457494
http://dx.doi.org/10.3389/fonc.2022.949941

Ejemplares similares